Company

Rubedo Life Sciences

https://rubedolife.com/

Industrybiopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases

Funding raised

CompanyRoundDate
Rubedo Life SciencesSeries A Funding2024-04-22